Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 1 | — | — |
headache; fatigue; cold-like symptoms; This is a spontaneous report received from a Pharmacist from a sales representative. A female patient (unknown if pregnant) received BNT162b2 omicron (lp.8.1) (COVID-19 VACCINE OMICRON LP.8.1-MANUFACTURER UNKNOWN), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 11Sep2025 as dose number unknown, single. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 12Sep2025, outcome "unknown", described as "cold-like symptoms"; FATIGUE (non-serious) with onset 12Sep2025, outcome "unknown"; HEADACHE (non-serious) with onset 12Sep2025, outcome "unknown". It was unknown if therapeutic measures were taken as a result of headache, fatigue, nasopharyngitis. Additional information: HCP reported feeling headache, fatigue, and cold-like symptoms after getting the Covid vaccine and flu vaccine. It is unknown if vaccine was Pfizer product. Unknown if patient receive any other vaccines within 4 weeks PRIOR to the vaccine(s) for which they are reporting. Unknown if patient taking any other medications within 2 weeks of the event starting. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.